2022-02-11

[#DIV28SUPER] Faculty Positions in Addictions Research Available at The University of Connecticut School of Medicine

Sent on behalf of Dr. Lance Bauer:

 

MULTIPLE TENURE TRACK FACULTY POSITIONS AVAILABLE IN ADDICTIONS RESEARCH.

The University of Connecticut School of Medicine seeks applications for 2 faculty positions in addictions research. The positions are tenure-track with 12-month full salary. Mid- or senior-level PhD or MD applicants are preferred.  Active grant-supported research is required.  Successful candidates will join an established and growing pool of addiction researchers (e.g., a P50-funded alcohol research center, T32 postdoctoral training program, behavioral health intervention group).  The UConn School of Medicine offers a highly competitive benefits package, including a tuition waiver for dependent children for University of Connecticut undergraduate degree programs.  For more information, consult jobs.uchc.edu (filter by: Department of Psychiatry and select Search # 2021-892; or Calhoun Cardiology Center and select Search # 2020-428) or contact: Professor Lance Bauer, Ph.D., Alcohol Research Center, University of Connecticut School of Medicine, 263 Farmington Ave., Farmington, CT  06030, Ph: 860-679-4154, lbauer@uchc.edu.

 

Best,

Brent Kaplan

Assistant Professor

Department of Family and Community Medicine

University of Kentucky

phone: 859-562-2714

email: brentkaplan@uky.edu

bio | github | researchgate

 

The information contained in this e-mail message may be privileged, confidential, and protected from disclosure. If you are not the intended recipient, any further disclosure, use, dissemination, distribution, or copying of this message or any attachment is strictly prohibited. Unauthorized interception or disclosure of this e-mail violates federal criminal law. If you think you have received this e-mail message in error, please delete it and notify the sender immediately.

2022-02-02

[#DIV28SUPER] Full-time Clinical Interviewer Position, Substance Use in Pregnancy, Brown Medical School

Dear Colleagues--

     We are seeking a Clinical Research Assistant for several NIH research studies of pregnancy substance use and infant development at Brown Medical School, Providence, RI. I would welcome any help in distributing the position posting below and attached. 

     Please feel free to contact me with any questions!  

Best regards,
Laura Stroud 

Clinical Research Assistant (Clinical Interviewer):

Substance use during pregnancy and infant development

Brown Medical School & The Miriam Hospital

BA/BS Required

 

The Center for Behavioral and Preventive Medicine at The Miriam Hospital, a Brown University teaching hospital, is seeking a Clinical Research Assistant to conduct clinical interviews and process various biospecimens for longitudinal studies investigating maternal substance use during pregnancy and fetal/infant neurobehavior.

 

The Clinical Research Assistant will work closely with PI, Dr. Laura Stroud, and other members of the BAMBAM Lab team. Opportunities to work with students and postdoctoral fellows in the lab are also available. Primary responsibilities involve clinical interviews of pregnant mothers, consenting, scheduling, and screening participants. Strong interpersonal and organizational skills preferred. Experience with clinical and or diagnostic interviewing and longitudinal studies desirable. Experience with electronic data capture/REDCap also desirable but not required. Position involves working in a fast-paced environment within a multidisciplinary research team. Potential need for schedule flexibility to accommodate participant visits. Other duties include, but are not limited to: (1) the collection, processing and storing of various biospecimens, which require participation in lab evening/weekend on-call rotation, (2) the recruitment of participants through community and OB office site posting and telephone screening efforts, (3) data cleaning, data analyses, and data programming tasks as needed. Personal transportation required.

 

The position is offered contingent upon the availability of funding. Lifespan is dedicated to diversity and creating an environment of inclusion. Employees are expected to embrace and successfully role model Lifespan's values of Compassion, Accountability, Respect, and Excellence. Lifespan is an Equal Opportunity / Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, ethnicity, sexual orientation, ancestry, genetics, gender identity or expression, disability, protected veteran or marital status.

 

To be considered for this position, please send a resume and cover letter to Dr. Nicole Belanger:

 NBelanger@Lifespan.org


--
Laura R. Stroud, Ph.D.
Professor | Department of Psychiatry and Human Behavior. Warren Alpert Medical School, Brown University
Director and Senior Research Scientist | Center for Behavioral and Preventive Medicine, The Miriam Hospital
Director | COBRE Center for Stress Trauma and Resilience (STAR)
Professor | Department of Behavioral and Social Sciences, School of Public Health, Brown University

Coro West, Suite 309
164 Summit Avenue
Providence, RI 02906
@LauraStroudPhD
@STAR_BrownDPHB

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Postdoctoral research positions examining chronic pain and opioid use disorder

University of New Mexico (UNM) Integrative Management of Chronic Pain and Opioid Use disorder for Whole Recovery Center

 

The Center on Alcohol, Substance use, And Addictions at the University of New Mexico (UNM) has two postdoctoral research opportunities on a newly awarded Center grant examining effectiveness, mechanisms, and implementation of integrated psychosocial treatments for chronic pain and opioid use disorder. The UNM Integrative Management of chronic Pain and Opioid use disorder for Whole Recovery (IMPOWR) Center will take an integrated and holistic approach to improving the lives of patients with chronic pain and opioid use disorder via tailored intervention approaches to meet the needs of diverse individuals in diverse communities. Our goals are to develop, test, and implement scalable, generalizable, and sustainable provider- and patient-level interventions that are focused on improving functioning and can be delivered in diverse health care settings using community-based participatory research approaches.

 

Each postdoctoral researcher will be tightly integrated into various UNM IMPOWR Center activities, with a strong emphasize on promoting and increasing diversity, and providing support to postdoctoral researchers in developing independent research careers as part of the UNM IMPOWR Center. Postdoctoral researchers will assist with recruitment, enrollment, retention, methodological development, data analysis, publications, and dissemination efforts for all projects. The UNM IMPOWR Center provides a NIH-defined stipend (based on years since doctoral degree), health insurance, support for professional travel, and support for training- and research-related expenses.

 

Interested applicants should submit a curriculum vitae and a 1-2 page cover letter that addresses their qualifications for and interest in a postdoctoral research position to Katie Witkiewitz, Ph.D., katiew@unm.edu. Applications received by March 15, 2022 will be given best consideration.

 

 

Katie Witkiewitz, PhD

Editor, Psychology of Addictive Behaviors

Regents’ Professor, Department of Psychology

Center on Alcohol, Substance Use, And Addictions (CASAA)

University of New Mexico

Logan Hall, Room 118

MSC 03-2220

Albuquerque, NM 87131

Lab website: https://abqresearch.org

Pronouns: She/Her/Hers 

 

 

2022-01-31

[#DIV28SUPER] Call for Nominations - APA Advisory Steering Committee for Development of Clinical Practice Guidelines

Dear Division 28 colleagues,

 

Apologies for cross-posting. Please forward the following announcement to your networks.

 

Thank you,

Jacob

Psychologist sought for position on APA clinical practice guideline advisory steering committee

Deadline for nominations is April 1, 2022

Nominations are invited for one position on the Advisory Steering Committee for Development of Clinical Practice Guidelines of the American Psychological Association (APA). The Advisory Steering Committee (ASC) oversees APA's process for clinical practice guideline development, including selection of topics for guidelines, recommendation of members for guideline development panels, and planning and assessment of guideline development processes. The term for the new position will begin in spring 2022, and the deadline for submitting nominations is April 1, 2022. Individuals are asked to self-nominate.

It is preferred, though not required, that the psychologist filling the open position have substantial background in at least one of the following areas:

  • Direct provision of psychological care in diverse practice settings or with diverse populations.
  • Child and/or family-focused clinical or research expertise.
  • Older adult-focused clinical or research expertise.
  • Direct provision of clinical treatment or services in the areas of mental health, physical health or health behaviors.
  • Behavioral medicine.
  • Health care financing.
  • Use of guidelines within systems or by direct providers.
  • Dissemination or implementation research.
  • Primary care work experience.
  • Expertise in intervention research (including efficacy and change processes).
  • Expertise in quantitative research methods (especially, clinical trials and other methods for causal inference).
  • Expertise in qualitative (including mixed) research methods and synthesis of qualitative findings.

Psychologists from a variety of perspectives and orientations (e.g., psychodynamic, cognitive-behavioral, family systems, humanistic) are encouraged to apply.  Psychologists with experience providing interventions to, conducting research with, or implementing clinical practice guidelines with diverse populations are especially encouraged to apply.

Work of the Advisory Steering Committee

So far, APA has developed and adopted three clinical practice guidelines in the areas of treatment of PTSD in adults (2017), obesity and overweight in children and adolescents (2018), and depression across the lifespan (2019).  There are currently two active guideline development panels: one on the treatment of chronic musculoskeletal pain and another on updating APA’s (2017) clinical practice guideline for treatment of PTSD in adults.

With assistance from APA staff, the work of the Advisory Steering Committee (ASC) includes: 

  1. Design and assessment of the policies and procedures by which APA develops clinical practice guidelines.
  2. Selection of topics for development of clinical practice guidelines.
  3. Recommendations to the APA Board of Directors of individuals to serve on clinical practice guideline development panels.
  4. Formulation of policies for commissioning and utilizing independent systematic reviews of empirical research to inform the development of clinical practice guidelines.
  5. Planning the structure and format of guideline documents and related products.
  6. Designing strategies for enhancing the dissemination and implementation of clinical practice guidelines.
  7. Evaluation of the effectiveness and impacts of clinical practice guidelines.
  8. Provision of progress reports to the Board of Directors and other APA governance groups. 

Over the next several years, the ASC will select new topics for guideline development and recommend members of guideline development panels for those topics. The ASC will also design strategies for disseminating APA guidelines, encouraging their implementation by health care providers and organizations, and evaluating their impact. Further, the ASC aims to build relationships with other organizations to collaborate in developing and disseminating clinical practice guidelines.  The ASC provides direction to APA's overall efforts in clinical practice guideline development but does not itself engage in the writing of guidelines or the conduct of systematic reviews.

The ASC reports to the Board of Directors, with additional oversight by the Board of Professional Affairs and Board of Scientific Affairs. Staff from the APA Practice Directorate and Science Directorate support the ASC's activities.

As currently authorized, the ASC has positions for ten individuals. Each member serves for a term of three years, with the possibility of renewal for a second term. All future work of the ASC is contingent on APA policy and funding.

During their tenure, ASC members are expected to:

  • Attend up to three extended meetings (with each meeting being either two full days in person in Washington, D.C. or a series of half-day virtual meetings) per year. These may include meetings of the ASC and/or meetings of guideline development panels.  Travel expenses for any in-person meetings are paid by APA.
  • Participate in monthly 1.5-hour conference calls and review materials between calls.
  • Engage in communication with ASC colleagues and APA staff via email.
  • Serve on at least one sub-group of the ASC (e.g., topic selection sub-committee, dissemination and implementation sub-committee).

Current Membership

The current members of the ASC are:

  • Jamile Ashmore

Baylor Scott & White The Heart Hospital – Plano

 

  • Marni Axelrad

Texas Children’s Hospital – Houston

 

  • Anil Chacko

New York University

 

  • Claire Collie (Chair)

Veterans Affairs Central Office

 

  • Brandon Gaudiano

Butler Hospital

 

  • David Haaga

American University

 

  • Evan Mayo-Wilson

Indiana University – Bloomington

 

  • J. Christopher Muran

Adelphi University

 

  • Stacy Ogbeide

University of Texas Health Science Center, San Antonio

 

  • Jacqueline B. Persons

Oakland Cognitive Behavior Therapy Center

Nomination Process and Review

All nominees should have 5 or more years of professional experience in clinical practice or clinical research (or combination thereof) and documented expertise in the general arena of evidence-based treatment development or implementation. Additionally, nominees should be nationally recognized via publications, professional awards, advanced credentials, involvement in professional organizations, and the like. Nominations of individuals who will enhance the diversity of the ASC are encouraged. Nominees should be members of the APA. However, current members of the Board of Directors, Board of Professional Affairs, and Board of Scientific Affairs are not eligible to serve on the ASC.

Nominees' materials will be reviewed initially by the ASC and by the Board of Professional Affairs and Board of Scientific Affairs.  A list of candidates will be submitted to the Board of Directors for it to make final selections and appointments. 

Review will include attention to nominees' areas of expertise, as well as their experience working with diverse patient populations (across race, ethnicity, language, gender, gender identity, sexual orientation, age, disability, class status, education, religious/spiritual orientation, and other cultural dimensions, as well as adult, adolescent and child patient populations) and within various clinical settings.

Nomination materials should include: 

  • Letter from the nominee indicating willingness to serve a three-year term.
  • Brief statement (up to three pages) of the nominee's expertise and qualifications related to the criteria described above. 
  • Nominee’s current curriculum vitae.

Nomination materials should be submitted by the nominees themselves. Endorsements from other individuals or groups are not expected. 

Nomination materials should be sent via email (cpg@apa.org) by April 1, 2022. In the event of questions or difficulties regarding email transmissions, please contact Project Manager for APA’s Clinical Practice Guidelines, Jacob Marzalik, MA, by email (jmarzalik@apa.org). 

Questions about the call and about APA's development of clinical practice guidelines can be directed to Raquel Halfond, PhD, Senior Director, Evidence Based Practice & Health Equity, via email (rhalfond@apa.org).

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

2022-01-24

[#DIV28SUPER] NIDA Neuroscience Update January 24, 2022

I.                     Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) RFA-DA-22-010

II.                   Accelerating the Pace of Drug Abuse Research Using Existing Data RFA-DA-22-037 and RFA-DA-22-028

III.                 Upcoming Funding Opportunity on Workshops on Computational and   Analytical Research Methods

 

------------

I.                    Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) RFA-DA-22-010

The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD mechanistic research.

-----

II.                 Accelerating the Pace of Drug Abuse Research Using Existing Data RFA-DA-22-037 and RFA-DA-22-028

R01 - https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-037.html

R21 - https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-038.html

 

Next Application deadline: March 4, 2022

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. Primary data collection is not allowed for applications in response to this FOA.

Posted Date: January 10, 2022

Funds Available and Anticipated Number of Awards: NIDA intends to commit $2 million in FY 2022 to fund 3-5 awards.

 

III.               Upcoming Funding Opportunity on Workshops on Computational and   Analytical Research Methods

 

The NIDA concept below may be of interest to you. FYI, a concept “describes the purpose, scope, and objectives of a potential funding opportunity. Concepts are posted to give interested researchers additional time to plan for application submissions. Approved concepts are usually developed into Requests For Applications (RFAs), Program Announcements that include set-aside funds (PASs), or Program Announcements with special receipt, referral and/or review considerations (PARs). The NACDA conducts most, but not all, NIDA concept clearances. Concepts may also be cleared through other public venues.”

Please feel free to share among your colleagues.

Workshops on Computational and Analytical Research Methods

Posted September 2021

Background

Neurocognitive studies have undergone transformative changes over the last decade. First, there has been a shift in the field towards pooling together smaller datasets (e.g., ENIGMA) or creating larger ones that are widely disseminated (e.g., Human Connectome Project, ABCD, HBCD). This shift has accelerated machine learning-based efforts towards prediction of substance use and psychiatric outcomes. Second, computational psychiatry has witnessed significant advances in explanatory modeling that seek to uncover neural computations underlying cognition, behavior, and associated dysfunction (e.g., reinforcement learning models applied towards dopamine’s role in reward learning and motivation). While major advancements have been made in the development of rigorous analytical and computational methods, their application in SUD research remains an area for further growth.

Goal

The purpose of this concept is to invite applications that disseminate analytical and computational methodologies and best practices through educational activities with hands-on research experience. The overall goals of this initiative are:

  1. Facilitating collaboration between clinical and computational researchers on SUD research
  2. Enhancing rigor and reproducibility towards better predictive models
  3. Broader application of sophisticated analytical and computational modeling approaches in SUD research
  4. Development of novel solutions to challenges faced in clinical application of computational psychiatry models

Primary: Vani Pariyadath, Ph.D., Chief, Behavioral and Cognitive Neuroscience Branch, Division of Neuroscience and Behavior

Elizabeth Hoffman, Ph.D., Scientific Program Manager (ABCD Project), Division of Extramural Research

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L

 

2022-01-21

[#DIV28SUPER] Seeking Nominations for the APA Board of Convention Affairs

Dear Colleagues,

 

We are seeking nominations for the APA Board of Convention Affairs (BCA). Here is a description of the role of BCA from the APA website:

 

"It shall be the responsibility of the Board of Convention Affairs to recommend policies and procedures to be followed in planning the Annual Convention, to coordinate the programs of Divisions and other organized groups within the Association, and to arrange for programs of general interest at the time of the annual convention."

 

Attached please find a description of what we are looking for in new members, members' responsibilities and the link where nominations are accepted. Nominations of self or others are accepted.

 

I am a member of BCA, so am happy to answer questions from any interested individuals.

 

Best,

 

Rob Leeman

 

 

Robert F. Leeman, Ph.D.
Associate Professor 

Mary F. Lane Endowed Professor 

Department of Health Education and Behavior 

College of Health and Human Performance 

Co-Director, NIH/NIAAA T32: Translational Science Training to Reduce the Impact of Alcohol on HIV Infection 

Associate Director, Southern HIV & Alcohol Research Consortium (SHARC) 

University of Florida 

Florida Gymnasium, Room 14 

PO Box 118210     Gainesville, FL  32611 

Phone: (352) 294-1808 

Email: robert.leeman@ufl.edu 

Faculty webpage: Robert Leeman, Ph.D. - College of Health and Human Performance (ufl.edu)

Lab webpage: EDGE Lab - College of Health and Human Performance (ufl.edu)

Twitter:@LeemanRobertF

 

2022-01-19

[#DIV28SUPER] Postdoctoral Fellow in Substance Use Disorder Research, University of Vermont, Vermont Center in Behavior and Health

The Vermont Center on Behavior and Health located at the Larner College of Medicine, University of Vermont announces a NIH (T32) postdoctoral research fellowship opportunity in our internationally-recognized center of excellence for substance use disorder research. The fellow will help will help to lead ongoing research involving pregnant and non-pregnant women with opioid and other substance use disorders. Applicants must have completed their training in psychology or a related discipline, be U.S. citizens or permanent residents, and have a commitment to a career substance use disorder research. For more information and to apply visit our website.



Stephen T. Higgins, Ph.D.
Director, Vermont Center on Behavior and Health
Virginia H. Donaldson Professor in Translational Science
Departments of Psychiatry and Psychological Science
University of Vermont
1 South Prospect Street, OH3, MS482
Burlington, VT  05401

VCBH Administrative Assistant: Susan Enos
susan.enos@uvm.edu
802-656-9615